Protalix Biotherapeutics Inc (NYSE American:PLX)

0.28
Delayed Data
As of 4:10pm ET
 +0.007 / +2.56%
Today’s Change
0.17
Today|||52-Week Range
0.60
-9.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues4.4M9.2M19.2M34.2M
 
 
 
 
 
Cost of Goods Sold730.0K6.4M13.3M7.6M
 
 
 
 
 
Depreciation And Amortization2.4M2.0M1.9M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income1.3M801.0K4.0M24.9M
 
 
 
 
 
General Expenses29.8M39.8M43.7M46.5M
 
 
 
 
 
Research And Development24.9M30.4M32.2M35.5M
 
 
 
 
 
Total Operating Expenses32.9M48.2M58.9M55.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.5M-39.0M-39.7M-21.5M
 
 
 
 
 
Extraordinary Credit0.0014.1M0.000.00
 
 
Extraordinary Charge0.000.00-39.4M0.00
 
 
Interest Expense On Debt3.7M10.7M9.7M7.7M
 
 
 
 
 
Other Expenses4.9M5.8M3.3M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.3M-29.2M-85.3M-26.5M
 
 
 
 
 
Discontinued Operations45.4M-189.0K0.000.00
 
 
 
Extraordinary Items39.9M0.000.000.00
 
 
Net Income18.1M-29.4M-85.3M-26.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.9M101.4M131.1M147.1M
 
 
 
 
 
Shares To Calculate EPS Diluted94.9M101.4M131.1M147.1M
 
 
 
 
 
 
Earnings Per ShareEPS$0.61-$0.29-$0.65-$0.18
 
 
 
 
 
EPS Diluted$0.19-$0.29-$0.65-$0.18